In today’s so-called consumer-driven landscape, no provider is exempt from the shifting attitudes. When it comes to pharmaceutical companies, it turns out patient expectations — not wishes, mind you — are quite high, and the industry can ill-afford to ignore the prevailing sentiment.
According a survey of 2,000 patients by Accenture , 76 percent think pharma companies “have a responsibility” to provide complimentary information and services around the products they sell.
Another 74 percent indicated that they wanted outreach when they start taking a medication, not afterward. To that end, the top four areas were patients are proactively seeking information are:
— medications, at 80 percent
— chronic conditions, at 75 percent
— healthcare services, at 71 percent
— illnesses and ailments, at 65 percent.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Images from Accenture.